BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9650599)

  • 1. Transfection of a vector expressing wild-type p53 into cells of two human glioma cell lines enhances radiation toxicity.
    Geng L; Walter S; Melian E; Vaughan AT
    Radiat Res; 1998 Jul; 150(1):31-7. PubMed ID: 9650599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
    Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
    Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
    Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis.
    Gomez-Manzano C; Fueyo J; Kyritsis AP; Steck PA; Roth JA; McDonnell TJ; Steck KD; Levin VA; Yung WK
    Cancer Res; 1996 Feb; 56(4):694-9. PubMed ID: 8630997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
    Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.
    Katayose D; Gudas J; Nguyen H; Srivastava S; Cowan KH; Seth P
    Clin Cancer Res; 1995 Aug; 1(8):889-97. PubMed ID: 9816059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
    Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
    Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus vector containing wild type p53 gene and its effect on human glioma cells.
    Hlavatý J; Tyukosova S; Bies J; Hlubinova K; Altaner C
    Neoplasma; 2000; 47(4):204-11. PubMed ID: 11043823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
    Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation.
    Srivastava S; Katayose D; Tong YA; Craig CR; McLeod DG; Moul JW; Cowan KH; Seth P
    Urology; 1995 Dec; 46(6):843-8. PubMed ID: 7502427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radioresistant variant derived from a human neuroblastoma cell line is less prone to radiation-induced apoptosis.
    Russell J; Wheldon TE; Stanton P
    Cancer Res; 1995 Nov; 55(21):4915-21. PubMed ID: 7585530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitivity of human breast cancer cells transduced with wild-type p53 gene is influenced by the p53 status of parental cells.
    Maeda T; Matsubara H; Koide Y; Sugaya M; Miyazawa Y; Tasaki K; Isono K; Ochiai T; Sakiyama S; Tagawa M
    Anticancer Res; 2000; 20(2A):869-74. PubMed ID: 10810368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?
    Naumann U; Durka S; Weller M
    Oncogene; 1998 Sep; 17(12):1567-75. PubMed ID: 9794234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-dependent thermal enhancement of cellular sensitivity in human squamous cell carcinomas in relation to LET.
    Takahashi A; Ohnishi K; Ota I; Asakawa I; Tamamoto T; Furusawa Y; Matsumoto H; Ohnishi T
    Int J Radiat Biol; 2001 Oct; 77(10):1043-51. PubMed ID: 11682009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramide triggers caspase activation during gamma-radiation-induced apoptosis of human glioma cells lacking functional p53.
    Hara S; Nakashima S; Kiyono T; Sawada M; Yoshimura S; Iwama T; Sakai N
    Oncol Rep; 2004 Jul; 12(1):119-23. PubMed ID: 15201971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
    Parker LP; Wolf JK; Price JE
    Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
    Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R
    Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.